DUBLIN--(BUSINESS WIRE)--The "Cystic Fibrosis Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.
The report on the global cystic fibrosis (CF) market provides qualitative and quantitative analysis for the period from 2017 to 2025.
The report predicts the global cystic fibrosis market to grow with a CAGR of 16.6% over the forecast period from 2019-2025. The study on cystic fibrosis market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.
The report on cystic fibrosis market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global cystic fibrosis market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global cystic fibrosis market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.
Report Findings
1) Drivers
- Growing prevalence of cystic fibrosis diseases
- Improvements in screening and treatments
2) Restraints
- The high cost of treatment
3) Opportunities
- Increasing global awareness for cystic fibrosis therapy,
- Technological advancements in the R&D
Key Topics Covered
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Cystic Fibrosis Market Highlights
2.2. Cystic Fibrosis Market Projection
2.3. Cystic Fibrosis Market Regional Highlights
3. Global Cystic Fibrosis Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Drug Class
3.4.2. IGR-Growth Matrix Analysis by Route of Administration
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Cystic Fibrosis Market
4. Cystic Fibrosis Market Macro Indicator Analysis
5. Global Cystic Fibrosis Market by Drug Class
5.1. CFTR Modulators
5.2. Mucolytic
5.3. Pancreatic Enzyme Supplements
5.4. Bronchodilators
5.5. Other Drug Classes
6. Global Cystic Fibrosis Market by Route of Administration
6.1. Inhaled Drugs
6.2. Oral Drugs
7. Global Cystic Fibrosis Market by Region
7.1. North America
7.1.1. North America Cystic Fibrosis Market by Drug Class
7.1.2. North America Cystic Fibrosis Market by Route of Administration
7.1.3. North America Cystic Fibrosis Market by Country
7.2. Europe
7.3. Asia-Pacific
7.4. RoW
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Cystic Fibrosis Market
8.2. Companies Profiled
8.2.1. Alcresta Therapeutics Inc.
8.2.2. AstraZeneca plc
8.2.3. Teva Pharmaceutical Industries
8.2.4. Allergan plc
8.2.5. Advanced Inhalation Therapies (AIT) Ltd.
8.2.6. F. Hoffmann-La Roche AG
8.2.7. Novartis International AG
8.2.8. Gilead Sciences Inc.
8.2.9. Vertex Pharmaceuticals Inc.
8.2.10. AbbVie Inc.
8.2.11. Other Companies
For more information about this report visit https://www.researchandmarkets.com/r/eac876
